COVID-19 Vaccination and Pregnancy: Single Hospital Case Report

L. Ratiani, N. Kintraia, P. Machavariani, K. Grigalashvili, T. Didbaridze, N. Metskhvarishvili, M. Rizvadze, E. Shvelashvili, MD Mikheil Gadabadze

Abstract


Reported case has been taken under consideration because of its close relation to the fact of vaccination against COVID-19 (Pfizer BionTech)  first dose.

Multiparous woman at age of 40 years with normal progressive 15 weeks of gestation, has been admitted to the University Clinic on the 10-th day after COVID -19 vaccination with general weakness, joint pain, severe to moderate head ache, fever, at the admission COVID-19 PCR testing occurs to be positive.

Following the protocol of COVID-19 pregnancy management anticoagulant treatment has been started (D-dimer 0.9 mg/dl). The   patient were under observation of infectious disease specialist.  Almost all other protocol based test results within normal ranges, on the 14-th day of vaccination gingival bleeding of moderate severity has been started together with progressive thrombocytopenia (63-103 m/L later 57-103 m/L), test of thromb agglutination was positive and the diagnose of idiopathic thrombocytopenia has been announced by hematologist.  Dexamethasone treatment has been initiated with following progressive positive results of thrombocyte count.  On the 12-th day of the admission with normal clinical and laboratory data’s patient has been discharged from the hospital with biweekly follow up for 8 weeks. All follow up laboratory values and clinical data were normal during this period. Based on literature, vaccination induced thrombocytopenia is a rare complication although has been documented and only several of them has proven to be vaccination induced complication. The reported case after assessment of patient’s history, clinical, lab data and VITT adapted scoring system revealed intermediate probability of VITT, coincidence of COVID-19 made difficulties for differentiation of thrombocytopenia reason which needs more accurate laboratory assessment, but unremarkable medical history and short time between vaccination and clinically revealed thrombocytopenia highly suspicious for VITT.


Keywords


covid-19, vaccination , pregnancy, thrombocytopenia

Full Text:

PDF

References


Pishko AM, Cuker A. Thrombosis After Vaccination With Messenger RNA-1273: Is ThisVaccine-Induced Thrombosis and Thrombocytopenia or Thrombosis With

Thrombocytopenia Syndrome? Ann Intern Med 2021.

Sangli S, Virani A, Cheronis N, et al. Thrombosis With Thrombocytopenia After the Messenger RNA-1273 Vaccine. Ann Intern Med 2021.

Greinacher A, Selleng, Wesche, Hendtake et al. Preprint, http://www

researchsquare.com/article/rs-440461/n1 (accessed on April 27/2021). Towards

understanding ChAdOx1nCov-19 vaccine induced immune thrombotic

thrombocytopenia

Schultz NH, Sorrol H, Michelsen AF. Et al. Thrombosis and thrombocytopenia after ChAdOx1nCov-19 vaccination. M Engl. J Med 2021:384-2124

Scull M, Singh D, Lown R, et al. Pathologic antibodies to platelet factor 4 after

ChAdOx1n Cov-19 vaccination. M Engl J. Med 2021. 384-2202.

Bayas A, Menacher M, Christ M et al, Bilateral superior ophthalmic vein thrombosis, ischemic stroke and immune thrombocytopenia after ChAdOx1nCov-19 vaccination. Lancet 2021. 397.

Muir RL, Kallam A, Koopsell SA, Gundabolu K. Thrombotic Thrombocitopenia after Ad26Cov2 vaccination. M Engl. J Med 2021, 384-0964.

Mahase E. AstraZeneca vaccine: Blood clots are "extremely rare" and benefits outweigh risks, regulators conclude. BMJ 2021; 373:n931.

Bikdeli B, Chatterjee S, Arora S, et al. Cerebral Venous Sinus Thrombosis in the

U.S. Population, After Adenovirus-Based SARS-CoV-2 Vaccination, and After

COVID-19. J Am Coll Cardiol 2021; 78:408.

Bhuyan P, Medin J, da Silva HG, et al. Very rare thrombosis with

thrombocytopenia after second AZD1222 dose: a global safety database

analysis. Lancet 2021; 398:577.

Greinacher A, Thiele T, Warkentin TE, et al. Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination. N Engl J Med 2021; 384:2092.

Schultz NH, Sørvoll IH, Michelsen AE, et al. Thrombosis and Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination. N Engl J Med 2021; 384:2124.

Pavord S, Scully M, Hunt BJ, et al. Clinical Features of Vaccine-Induced Immune Thrombocytopenia and Thrombosis. N Engl J Med 2021.

Bourguignon A, Arnold DM, Warkentin TE, et al. Adjunct Immune Globulin for

Vaccine-Induced Immune Thrombotic Thrombocytopenia. N Engl J Med 2021;

:720.

Scully M, Singh D, Lown R, et al. Pathologic Antibodies to Platelet Factor 4 after ChAdOx1 nCoV-19 Vaccination. N Engl J Med 2021; 384:2202.

Sangli S, Virani A, Cheronis N, et al. Thrombosis With Thrombocytopenia After

the Messenger RNA-1273 Vaccine. Ann Intern Med 2021.

Pishko AM, Cuker A. Thrombosis After Vaccination With Messenger RNA-1273: Is ThisVaccine-Induced Thrombosis and Thrombocytopenia or Thrombosis With Thrombocytopenia Syndrome? Ann Intern Med 2021.

Bayas A, Menacher M, Christ M, et al. Bilateral superior ophthalmic vein

thrombosis, ischaemic stroke, and immune thrombocytopenia after ChAdOx1

nCoV-19 vaccination. Lancet 2021; 397:e11.

Muir KL, Kallam A, Koepsell SA, Gundabolu K. Thrombotic Thrombocytopenia after Ad26.COV2.S Vaccination. N Engl J Med 2021; 384:1964.




DOI: http://dx.doi.org/10.52155/ijpsat.v29.2.3725

Refbacks

  • There are currently no refbacks.


Copyright (c) 2021 L. Ratiani, N. Kintraia, P. Machavariani, K. Grigalashvili, T. Didbaridze, N. Metskhvarishvili, M. Rizvadze, E. Shvelashvili

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.